| Previous close | 25.41 |
| Open | 25.41 |
| Bid | 26.45 |
| Ask | 27.25 |
| Strike | 60.00 |
| Expiry date | 2024-06-21 |
| Day's range | 25.41 - 25.41 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
Motley Fool3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
BioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts' price target reflects an upside potential of 56%. Granted, not every analyst is all that bullish about BioNTech.
Motley FoolCould Viatris Stock Help You Become a Millionaire?
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Motley FoolModerna's Shares Could Take Off if These 2 Things Happen
Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.
© 2023 Yahoo. All rights reserved.
